The diagnostic value of ischemia-modified albumin in the diagnosis of aortic pathology

To investigate the diagnostic value of ischemia-modified albumin (IMA) in the diagnosis of patients with aortic aneurysm. Materials and methods: The study group consisted of 98 patients who presented to our university hospital emergency department with aortic pathology and were definitively diagnosed using spiral tomography. The control group consisted of 101 healthy individuals with similar demographic characteristics. Results: Mean IMA values were 0.89 ± 0.21 absorbance units (ABSU) in the aortic aneurysm group (P < 0.001), 0.70 ± 0.12 ABSU in the aortic dissection group (P < 0.001), 0.98 ± 0.23 ABSU in the aneurysm and dissection group (P < 0.001), 0.84 ± 0.16 ABSU in the aneurysm and rupture group (P < 0.001), and 0.87 ± 0.27 ABSU in the aneurysm, dissection, and rupture group (P < 0.001). Mean IMA value for the subjects in the control group was 0.62 ± 0.17 ABSU. All the differences between the aortic pathology groups' IMA values and those of the control group were statistically significant (P < 0.001). Conclusion: On the basis of the findings from this study, serum IMA levels are higher in patients with aortic pathology compared to healthy individuals. This finding suggests that IMA may help to diagnose aortic pathology, but it requires confirmation by additional clinical studies.

Anahtar Kelimeler:

Key words: Ischemia-modified albumin, aortic aneurysm, aortic dissection, aortic rupture

The diagnostic value of ischemia-modified albumin in the diagnosis of aortic pathology

Keywords:

Key words: Ischemia-modified albumin, aortic aneurysm, aortic dissection, aortic rupture,

PDF

___

Kayan M, Yavuz T, Etli M, Benzin Ş, İbişoğlu S, Üstün ED, Köroğlu M, Ceylan E, Sağlam U. Endovascular treatment of abdominal aortic aneurysms with Endologix® stent graft: single-site experiences. Turk J Med Sci 2012; 42: 823–9.
Yuan SM, Shi YH, Wang JJ, Lü FQ, Gao S. Elevated plasma D-dimer and hypersensitive C-reactive protein levels may indicate aortic disorders. Rev Bras Cir Cardiovasc 2011; 26: 573–81.
Moriyama Y, Toyohira H, Koga M, Watanabe S, Saigenji H, Shimokawa S, Taira A. Influence of aortic dissection on the clotting-fibrinolysis system and platelet function. Int J Angiol 1998; 7: 65–7.
Keating L, Benger JR, Beetham R, Bateman S, Veysey S, Kendall J, Pullinger R. The PRIMA study: presentation ischemiamodified albumin in the emergency department. Emerg Med J 2006; 23: 764–8.
Weber T, Högler S, Auer J, Berent R, Lassnig E, Kvas E, Eber B. D-dimer in acute aortic dissection. Chest 2003; 123: 1375–8.
Suzuki T, Distante A, Zizza A, Trimarchi S, Villani M, Salerno Uriarte JA, De Luca Tupputi Schinosa L, Renzulli A, Sabino F, Nowak R et al. Diagnosis of acute aortic dissection by D-dimer: the International Registry of Acute Aortic Dissection Substudy on Biomarkers (IRAD-Bio) experience. Circulation 2009; 119: 2702–7.
Sbarouni E, Georgiadou P, Marathias A, Geroulanos S, Kremastinos DT. D-dimer and BNP levels in acute aortic dissection. Int J Cardiol 2007; 122: 170–2.
Turedi S, Gunduz A, Mentese A, Topbas M, Karahan SC, Yeniocak S, Turan I, Eroglu O, Ucar U, Karaca Y et al. The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism. Respir Res 2008; 30: 9–49.
Abboud H, Labreuche J, Meseguer E, Lavallee PC, Simon O, Olivot JM, Mazighi M, Dehoux M, Benessiano J, Steg PG et al. Ischemia-modified albumin in acute stroke. Cerebrovasc Dis 2007; 23: 216–20.
Zuwała-Jagiełło J, Warwas M, Pazgan-Simon M. Ischemiamodified albumin (IMA) is increased in patients with chronic hepatitis C infection and related to markers of oxidative stress and inflammation. Acta Biochim Pol 2012; 59: 661–7.
Prydz H, Camerer E, Rottingen JA, Wiiger MT, Gjernes E. Cellular consequences of the initiation of blood coagulation. Thromb Haemost 1999; 82: 183–92.
Peacock F, Morris DL, Anwaruddin S, Christenson RH, Collinson PO, Goodacre SW, Januzzi JL, Jesse RL, Kaski JC, Kontos MC et al. Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J 2006; 152: 253–62.
Bar-Or D, Winkler JV, Vanbenthuysen K, Harris L, Lau E, Hetzel FW. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J 2001; 141: 985–91.
Turedi S, Gunduz A, Mentese A, Karahan SC, Yilmaz SE, Eroglu O, Nuhoglu I, Turan I, Topbas M. Value of ischemiamodified albumin in the diagnosis of pulmonary embolism. Am J Emerg Med 2007; 25: 770–3.
Gunduz A, Turedi S, Mentese A, Karahan SC, Hos G, Tatli O, Turan I, Ucar U, Russell RM, Topbas M. Ischemia-modified albumin in the diagnosis of acute mesenteric ischemia: a preliminary study. Am J Emerg Med 2008; 26: 202–5.
Nienaber CA, Sievers HH. Intramural hematoma in acute aortic syndrome: more than one variant of dissection? Circulation 2002; 106: 284–5.
Sen C, Madazlı R, Ocak V. Gebelikte hipertansiyon tanım ve sınıflandırma. Perinatoloji Dergisi 1993; 1: 7–10 (article in Turkish).
Gunduz A, Mentese A, Turedi S, Karahan SC, Mentese U, Eroglu O, Turkmen S, Turan I, Ucar U, Russell R. Serum ischemia-modified albumin increases in critical lower limb ischemia. Emerg Med J 2008; 25: 351–3.
Kutlu O, Mentese A, Turkmen S, Turedi S, Gunduz A, Yulug E, Alver A, Karahan SC. Investigation of the possibility of using ischemia-modified albumin in testicular torsion: an experimental study. Fertil Steril 2011; 15: 1333–7.